BMF was found to be positively correlated with RBMS2 in both TIMER (Tumor Immune Estimation Resource, https://cistrome.shinyapps.io/timer) database (Fig. 4B) and the breast cancer samples from our hospital (Fig. 4C). This evidence concerns the gene RBMS2 and neoplasm.